(Q51743407)

11 April 2018

title

D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine. (English)

1 reference

11 April 2018

0 references

H Ujike

1

1 reference

11 April 2018

K Akiyama

series ordinal

2

1 reference

11 April 2018

S Otsuki

series ordinal

3

1 reference

11 April 2018

publication date

1 January 1990

1 reference

11 April 2018

published in

Psychopharmacology

1 reference

11 April 2018

volume

102

1 reference

11 April 2018

page(s)

459-464

1 reference

11 April 2018

issue

4

1 reference

11 April 2018

https://scigraph.springernature.com/pub.10.1007/bf02247125

exact match

0 references

cites work

Evolving behavior in the clinical and experimental amphetamine (model) psychosis.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02247125

Cocaine, kindling, and psychosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02247125

Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy

21 January 2018

1 reference

12 December 2020

Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390

1 reference

12 December 2020

Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems

1 reference

12 December 2020

Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior.

1 reference

12 December 2020

Stereotyped behaviour in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK&F 38393.

1 reference

12 December 2020

Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.

1 reference

12 December 2020

Chronic amphetamine alters D-2 but not D-1 agonist-induced behavioral responses in rats.

1 reference

12 December 2020

Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment

1 reference

12 December 2020

Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity

1 reference

12 December 2020

D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects

1 reference

12 December 2020

Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis

1 reference

12 December 2020

Localization of D-2 dopamine receptors to intrinsic striatal neurones by quantitative autoradiography.

1 reference

12 December 2020

Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study

1 reference

12 December 2020

Acute and chronic amphetamine treatments modulate striatal dopamine receptor binding sites

1 reference

12 December 2020

Long-term d-amphetamine in rats: lack of change in post-synaptic dopamine receptor sensitivity

1 reference

12 December 2020

Dopaminergic denervation increases [3H](+)-amphetamine binding in the rat striatum.

1 reference

12 December 2020

Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence

1 reference

12 December 2020

Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization

1 reference

12 December 2020

Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors

1 reference

12 December 2020

The actions of amphetamine on neurotransmitters: a brief review

1 reference

12 December 2020

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

1 reference

12 December 2020

Subchronic cocaine treatment enhances cocaine-induced dopamine efflux, studied by in vivo intracerebral dialysis.

1 reference

12 December 2020

Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.

1 reference

12 December 2020

Increasing effects of repetitive cocaine administration in the rat

1 reference

12 December 2020

Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats.

1 reference

12 December 2020

Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis

1 reference

12 December 2020

Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo.

1 reference

12 December 2020

The D-2 agonist quinpirole releases striatal dopamine in vivo.

1 reference

12 December 2020

Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors

1 reference

12 December 2020

Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02247125

1 reference

11 April 2018

PubMed ID

2151400

1 reference

11 April 2018